Drug Research
FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised
The FDA authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus.
The FDA issued an emergency use authorization Wednesday for AstraZeneca’s antibody cocktail,...
Drug Research
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders.
Under the terms of the agreement, Lilly will have a license to...
Drug Research
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours...
Drug Research
Roquette Reveals New US-Based Pharmaceutical Innovation Center
Roquette, a global leader in plant-based ingredients and a leading provider of naturally-derived pharmaceutical excipients, announces its plans to open a new Innovation Center in the US to further the advancement of prescription drugs – and beyond. Located in...
Drug Research
Operations commence at Genezen’s lenti- and retroviral vector process development lab
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has officially opened its new process development and analytical lab.
The lab will deliver a full...
Drug Research
Nykode Therapeutics Selects BioConnection to Manufacture Lead Vax Candidate
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, announced that it has entered into a license and collaboration agreement with Regeneron for the discovery, development and commercialization of potential new...
Drug Research
Lonza and Bioqube Ventures Sign a Framework Agreement for the Future Development of Biologics and Small Molecules for Bioqubes Portfolio Companies
Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, today announced a framework agreement covering a strategic collaboration...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
